Calyxt Inc (NASDAQ:CLXT) CFO Bryan W.J. Corkal sold 5,093 shares of the business’s stock in a transaction that occurred on Friday, June 15th. The stock was sold at an average price of $18.77, for a total transaction of $95,595.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
NASDAQ:CLXT opened at $20.78 on Tuesday. The firm has a market capitalization of $560.98 million and a PE ratio of -18.55. Calyxt Inc has a twelve month low of $9.26 and a twelve month high of $31.89. The company has a debt-to-equity ratio of 0.27, a current ratio of 17.79 and a quick ratio of 17.79.
Calyxt (NASDAQ:CLXT) last issued its quarterly earnings results on Monday, May 7th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.29) by $0.13. The firm had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.20 million. Calyxt had a negative net margin of 5,930.60% and a negative return on equity of 60.81%. analysts forecast that Calyxt Inc will post -1.14 EPS for the current fiscal year.
Several analysts have recently weighed in on the stock. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price objective on shares of Calyxt in a research note on Thursday, March 1st. Zacks Investment Research upgraded shares of Calyxt from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research note on Monday, May 28th. Finally, ValuEngine upgraded shares of Calyxt from a “sell” rating to a “hold” rating in a research note on Wednesday, March 14th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Calyxt presently has an average rating of “Buy” and an average target price of $27.38.
Several hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. lifted its position in shares of Calyxt by 102.8% in the 4th quarter. BlackRock Inc. now owns 740,010 shares of the company’s stock worth $16,302,000 after purchasing an additional 375,137 shares during the period. Wells Fargo & Company MN lifted its position in shares of Calyxt by 23.6% in the 1st quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock worth $500,000 after purchasing an additional 7,260 shares during the period. Deutsche Bank AG lifted its position in shares of Calyxt by 151.3% in the 4th quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock worth $404,000 after purchasing an additional 11,064 shares during the period. Finally, Goldman Sachs Group Inc. bought a new stake in shares of Calyxt in the 4th quarter valued at $330,000. Hedge funds and other institutional investors own 21.78% of the company’s stock.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.